Cargando…

French recommendations for the management of glycogen storage disease type III

The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicker, Camille, Cano, Aline, Decostre, Valérie, Froissart, Roseline, Maillot, François, Perry, Ariane, Petit, François, Voillot, Catherine, Wahbi, Karim, Wenz, Joëlle, Laforêt, Pascal, Labrune, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364360/
https://www.ncbi.nlm.nih.gov/pubmed/37488624
http://dx.doi.org/10.1186/s40001-023-01212-5
_version_ 1785076827710029824
author Wicker, Camille
Cano, Aline
Decostre, Valérie
Froissart, Roseline
Maillot, François
Perry, Ariane
Petit, François
Voillot, Catherine
Wahbi, Karim
Wenz, Joëlle
Laforêt, Pascal
Labrune, Philippe
author_facet Wicker, Camille
Cano, Aline
Decostre, Valérie
Froissart, Roseline
Maillot, François
Perry, Ariane
Petit, François
Voillot, Catherine
Wahbi, Karim
Wenz, Joëlle
Laforêt, Pascal
Labrune, Philippe
author_sort Wicker, Camille
collection PubMed
description The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providing tools that make the diagnosis, defining the severity and different damages of the disease by detailing tests and explorations required for monitoring and diagnosis, better understanding the different aspects of the treatment, defining the modalities and organisation of the monitoring. This is a practical tool, to which health care professionals can refer. PNDS cannot, however, predict all specific cases, comorbidities, therapeutic particularities or hospital care protocols, and does not seek to serve as a substitute for the individual responsibility of the physician in front of his/her patient.
format Online
Article
Text
id pubmed-10364360
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103643602023-07-25 French recommendations for the management of glycogen storage disease type III Wicker, Camille Cano, Aline Decostre, Valérie Froissart, Roseline Maillot, François Perry, Ariane Petit, François Voillot, Catherine Wahbi, Karim Wenz, Joëlle Laforêt, Pascal Labrune, Philippe Eur J Med Res Review The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providing tools that make the diagnosis, defining the severity and different damages of the disease by detailing tests and explorations required for monitoring and diagnosis, better understanding the different aspects of the treatment, defining the modalities and organisation of the monitoring. This is a practical tool, to which health care professionals can refer. PNDS cannot, however, predict all specific cases, comorbidities, therapeutic particularities or hospital care protocols, and does not seek to serve as a substitute for the individual responsibility of the physician in front of his/her patient. BioMed Central 2023-07-24 /pmc/articles/PMC10364360/ /pubmed/37488624 http://dx.doi.org/10.1186/s40001-023-01212-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Wicker, Camille
Cano, Aline
Decostre, Valérie
Froissart, Roseline
Maillot, François
Perry, Ariane
Petit, François
Voillot, Catherine
Wahbi, Karim
Wenz, Joëlle
Laforêt, Pascal
Labrune, Philippe
French recommendations for the management of glycogen storage disease type III
title French recommendations for the management of glycogen storage disease type III
title_full French recommendations for the management of glycogen storage disease type III
title_fullStr French recommendations for the management of glycogen storage disease type III
title_full_unstemmed French recommendations for the management of glycogen storage disease type III
title_short French recommendations for the management of glycogen storage disease type III
title_sort french recommendations for the management of glycogen storage disease type iii
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364360/
https://www.ncbi.nlm.nih.gov/pubmed/37488624
http://dx.doi.org/10.1186/s40001-023-01212-5
work_keys_str_mv AT wickercamille frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT canoaline frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT decostrevalerie frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT froissartroseline frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT maillotfrancois frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT perryariane frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT petitfrancois frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT voillotcatherine frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT wahbikarim frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT wenzjoelle frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT laforetpascal frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii
AT labrunephilippe frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii